The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Tue, 01st Jun 2021 15:51

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Tekmar Group PLC - provider of technology and services for offshore energy markets - Hires Derek Bulmer as new chief financial officer. Sue Hurst, the current CFO, steps down from the role on Tuesday but will remain on the board for a transition period. Bulmer was CFO and in-house counsel for AIM-listed radiation detection technology firm Kromek Group PLC from 2010 until last year. Prior to Kromek, he had worked at brick maker Ibstock PLC, among other employers. Tekmar also announced its annual results on Tuesday. For the 12 months ended March 31, it swung to pretax loss of GBP2.5 million from a profit of GBP2.0 million the year before, on revenue which declined 29% to GBP29.1 million from GBP40.9 million.

----------

Redx Pharma PLC - Macclesfield, England-based discovery of treatments for cancer and fibrotic disease - Chair Iain Ross steps down as a director immediately "to pursue other business opportunities". Redx makes Independent Non-Executive Director Peter Presland the interim chair as it starts search for new chair. "Iain has been the lynchpin in the turnaround of Redx, and we are very grateful for his innumerable contributions as chairman over the last four years," says Chief Executive Officer Lisa Anson. Ross says he remains "a supportive shareholder".

----------

Chamberlin PLC - West Midlands-based castings and engineering - New CEO Kevin Price and new Finance Director Alan Tomlinson join the board on Tuesday. Non-Executive Director Trevor Brown moves to executive director, responsible for company strategy, effective immediately, while David Flowerday resigns as non-executive director from Monday.

----------

Challenger Energy Group PLC - assets in Bahamas, Uruguay, Trinidad & Tobago and Suriname, previously known as Bahamas Petroleum Co PLC - Eytan Uliel formally takes up role as CEO. Simon Potter steps down as CEO but remains as non-executive director. Stephen Bizzell joins board as non-executive director, replacing Ross McDonald.

----------

Longboat Energy PLC - North Sea-focused exploration and production - Hires Nick Ingrassia as corporate development director. Ingrassia had joined Longboat back in September. Among other roles, he had worked at Faroe Petroleum PLC, whose former management team are behind Longboat Energy. Ingrassia's appointment comes alongside Longboat's announcement on Tuesday of three acquisitions to develop an exploration drilling programme on the Norwegian continental shelf. The acquisitions will be accompanied by a GBP35 million equity raise and are classified as a reverse takeover of Longboat under AIM rules.

----------

Trustpilot AS - Copenhagen-based online consumer reviews platform - Hires Joe Hurd as independent non-executive director. California-based Hurd is an independent public board director and adviser.

----------

India Capital Growth Fund Ltd - invests directly, or indirectly, in companies based in India - Hires Lynne Duquemin as non-executive director, effective immediately, as successor to Peter Niven, who will retire from the board at the end of 2021. Duquemin is a Guernsey resident with "deep experience of investment management and advisory services".

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2016 09:44

Redx Pharma Makes Progress On Gonorrhoea Treatment And Other Drugs

Read more
20 Jan 2016 10:00

Redx Pharma Continues Pipeline Progressing In Maiden Results

Read more
13 Jan 2016 16:00

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jan 2016 08:35

New Redx director brings scientific, commercial expertise

(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph

Read more
3 Dec 2015 07:54

Redx Pharma Identifies New Cancer Drug Development Candidate

Read more
6 Nov 2015 09:42

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Read more
1 Oct 2015 07:36

Redx Pharma Says It Made "Good Progress" In Second Half

Read more
3 Sep 2015 08:00

Redx Pharma And Horizon Discovery Collaborating On Cancer Research

Read more
22 Jun 2015 14:17

Redx Pharma enjoys good progress during first-half

Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d

Read more
22 Jun 2015 08:35

Redx Pharma Positive For Full Year, Loss Widens In Maiden Interims

Read more
2 Jun 2015 11:13

Redx Pharma cheers with progress on potential MRSA drug

Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial

Read more
2 Jun 2015 07:00

Redx Pharma Progresses To Pre-Clinical Stage With MRSA Treatment

Read more
26 May 2015 07:43

Redx Pharma Identifies Second Drug Development Candidate

Read more
14 May 2015 09:41

Redx Pharma To Launch New Immunology Subsidiary

Read more
14 May 2015 08:55

Redx Pharma Says Third Paper On Antimicrobial Resistance Published

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.